You are on page 1of 2

The Business Model Canvas

Designed for: Healx’s Business Model Designed by: Bermillo, Shekainah Glory Date: 10/28/2021 Version:

Key Partners Key Activities Value Propositions Customer Relationships Customer Segments
• They necesse asset sharing and • concentrating on individuals with • The presence of rare-disease a • They add value to the lives of sick and/or
personalization uncommon diseases rare-disease patients.
• Cambridge Judge Business School • Asset sharing
• Healx value proposition was about asset • Treating patients with uncommon diseases
• Tech venture Healx sharing and providing them with information about • With Healx's support, their lives were a lot
them less terrible. • The most significant clients are those who
• The business accelerator • Big pharma and health care provider are terminally ill.
• It was expensive before, but with Healx's
• Treatment of patients • Giving companies an incentive help, it became cheap.
• Empowering patients by providing them
with a wealth of information prior to seeking • They are all, since they all want to be
medical advice. treated.

Key Resources • Their technology may be able to assist Channels


businesses foresee such failures with high
• It evaluated the amount of drug accuracy, potentially saving millions of • Other companies gave their data to pay
information already available to patients with pounds per year. back the Healx paying incentive to other
uncommon disorders. companies

• They started with 1,000 of the 7,000 rare • Healx is better because of the advanced
diseases with formal advocacy groups around • Informing others and developed machinery that made it more
the world. convenient for humans to get accurate
results
• by examining the fraction of known data
on medications that are relevant to rare • Healx is better because of the advanced
diseases and developed machinery that made it more
convenient for humans to get accurate
• There are 350 million people , with 95 results
percent of them receiving no prescription
suggestions that are even remotely relevant. • It will be costly to develop, but it will be
helpful to everyone.
• If a costly therapy fails to help a patient,
the firm that provided it may be obliged to
reimburse NHS providers.

• Cost Structure Revenue Streams


•The most major cost is taking data from other companies and paying incentives for their data or ideas. • Customers will gladly pay for a good service, an accurate outcome, and more information.
• The most expensive key resource is the data on everything and the beginning point. • They are paying for additional information and description.
• The most expensive key activity was developing the machine.
• They make money by collecting data and developing treatments for rare diseases. Consequently, profit is made.

• Despite spending a lot of money on research, they are known for selling pharmaceuticals at a reasonable price.
However, it doesn't really matter because they're thinking about a win-win situation.

You might also like